Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Intramuscular Drug Delivery Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Drug Molecule
    • 1.4.3 Delivery Devices
  • 1.5 Market by Application
    • 1.5.1 Global Intramuscular Drug Delivery Market Share by Application: 2020 VS 2026
    • 1.5.2 Infectious Disease
    • 1.5.3 Oncology
    • 1.5.4 Autoimmune Diseases
  • 1.6 Coronavirus Disease 2019 (Covid-19): Intramuscular Drug Delivery Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Intramuscular Drug Delivery Industry
      • 1.6.1.1 Intramuscular Drug Delivery Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Intramuscular Drug Delivery Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Intramuscular Drug Delivery Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Intramuscular Drug Delivery Market Perspective (2015-2026)
  • 2.2 Intramuscular Drug Delivery Growth Trends by Regions
    • 2.2.1 Intramuscular Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Intramuscular Drug Delivery Historic Market Share by Regions (2015-2020)
    • 2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Intramuscular Drug Delivery Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Intramuscular Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Intramuscular Drug Delivery Players by Market Size
    • 3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2015-2020)
    • 3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Intramuscular Drug Delivery Market Concentration Ratio
    • 3.2.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2019
  • 3.3 Intramuscular Drug Delivery Key Players Head office and Area Served
  • 3.4 Key Players Intramuscular Drug Delivery Product Solution and Service
  • 3.5 Date of Enter into Intramuscular Drug Delivery Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2015-2020)
  • 4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Intramuscular Drug Delivery Breakdown Data by Application (2015-2026)

  • 5.1 Global Intramuscular Drug Delivery Market Size by Application (2015-2020)
  • 5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Intramuscular Drug Delivery Market Size (2015-2020)
  • 6.2 Intramuscular Drug Delivery Key Players in North America (2019-2020)
  • 6.3 North America Intramuscular Drug Delivery Market Size by Type (2015-2020)
  • 6.4 North America Intramuscular Drug Delivery Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Intramuscular Drug Delivery Market Size (2015-2020)
  • 7.2 Intramuscular Drug Delivery Key Players in Europe (2019-2020)
  • 7.3 Europe Intramuscular Drug Delivery Market Size by Type (2015-2020)
  • 7.4 Europe Intramuscular Drug Delivery Market Size by Application (2015-2020)

8 China

  • 8.1 China Intramuscular Drug Delivery Market Size (2015-2020)
  • 8.2 Intramuscular Drug Delivery Key Players in China (2019-2020)
  • 8.3 China Intramuscular Drug Delivery Market Size by Type (2015-2020)
  • 8.4 China Intramuscular Drug Delivery Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Intramuscular Drug Delivery Market Size (2015-2020)
  • 9.2 Intramuscular Drug Delivery Key Players in Japan (2019-2020)
  • 9.3 Japan Intramuscular Drug Delivery Market Size by Type (2015-2020)
  • 9.4 Japan Intramuscular Drug Delivery Market Size by Application (2015-2020)

10 Key Players Profiles

  • 10.1 Antares Pharma
    • 10.1.1 Antares Pharma Company Details
    • 10.1.2 Antares Pharma Business Overview and Its Total Revenue
    • 10.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
    • 10.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2015-2020))
    • 10.1.5 Antares Pharma Recent Development
  • 10.2 Eli Lily
    • 10.2.1 Eli Lily Company Details
    • 10.2.2 Eli Lily Business Overview and Its Total Revenue
    • 10.2.3 Eli Lily Intramuscular Drug Delivery Introduction
    • 10.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.2.5 Eli Lily Recent Development
  • 10.3 Galaxo
    • 10.3.1 Galaxo Company Details
    • 10.3.2 Galaxo Business Overview and Its Total Revenue
    • 10.3.3 Galaxo Intramuscular Drug Delivery Introduction
    • 10.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.3.5 Galaxo Recent Development
  • 10.4 HMD pharmaceuticals
    • 10.4.1 HMD pharmaceuticals Company Details
    • 10.4.2 HMD pharmaceuticals Business Overview and Its Total Revenue
    • 10.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
    • 10.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.4.5 HMD pharmaceuticals Recent Development
  • 10.5 Inovio Pharmaceuticals
    • 10.5.1 Inovio Pharmaceuticals Company Details
    • 10.5.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
    • 10.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
    • 10.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.5.5 Inovio Pharmaceuticals Recent Development
  • 10.6 Merck
    • 10.6.1 Merck Company Details
    • 10.6.2 Merck Business Overview and Its Total Revenue
    • 10.6.3 Merck Intramuscular Drug Delivery Introduction
    • 10.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.6.5 Merck Recent Development
  • 10.7 Novartis
    • 10.7.1 Novartis Company Details
    • 10.7.2 Novartis Business Overview and Its Total Revenue
    • 10.7.3 Novartis Intramuscular Drug Delivery Introduction
    • 10.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.7.5 Novartis Recent Development
  • 10.8 Pacira Pharmaceuticals
    • 10.8.1 Pacira Pharmaceuticals Company Details
    • 10.8.2 Pacira Pharmaceuticals Business Overview and Its Total Revenue
    • 10.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
    • 10.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.8.5 Pacira Pharmaceuticals Recent Development
  • 10.9 Pfizer
    • 10.9.1 Pfizer Company Details
    • 10.9.2 Pfizer Business Overview and Its Total Revenue
    • 10.9.3 Pfizer Intramuscular Drug Delivery Introduction
    • 10.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.9.5 Pfizer Recent Development
  • 10.10 Pharmajet
    • 10.10.1 Pharmajet Company Details
    • 10.10.2 Pharmajet Business Overview and Its Total Revenue
    • 10.10.3 Pharmajet Intramuscular Drug Delivery Introduction
    • 10.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.10.5 Pharmajet Recent Development
  • 10.11 Teva Pharmaceutical
    • 10.11.1 Teva Pharmaceutical Company Details
    • 10.11.2 Teva Pharmaceutical Business Overview and Its Total Revenue
    • 10.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
    • 10.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2015-2020)
    • 10.11.5 Teva Pharmaceutical Recent Development

11 Analyst's Viewpoints/Conclusions

    12 Appendix

    • 12.1 Research Methodology
      • 12.1.1 Methodology/Research Approach
      • 12.1.2 Data Source
    • 12.2 Disclaimer

    This report focuses on the global Intramuscular Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intramuscular Drug Delivery development in North America, Europe, China and Japan.

    The key players covered in this study
    Antares Pharma
    Eli Lily
    Galaxo
    HMD pharmaceuticals
    Inovio Pharmaceuticals
    Merck
    Novartis
    Pacira Pharmaceuticals
    Pfizer
    Pharmajet
    Teva Pharmaceutical

    Market segment by Type, the product can be split into
    Drug Molecule
    Delivery Devices
    Market segment by Application, split into
    Infectious Disease
    Oncology
    Autoimmune Diseases

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan

    The study objectives of this report are:
    To analyze global Intramuscular Drug Delivery status, future forecast, growth opportunity, key market and key players.
    To present the Intramuscular Drug Delivery development in North America, Europe, China and Japan.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Intramuscular Drug Delivery are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now